|
1
|
Townsend DM and Tew KD: The role of
glutathione-S-transferase in anti-cancer drug resistance. Oncogene.
22:7369–7375. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chatterjee A and Gupta S: The multifaceted
role of glutathione S-transferases in cancer. Cancer Lett.
433:33–42. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eaton DL and Bammler TK: Concise review of
the glutathione S-transferases and their significance to
toxicology. Toxicol Sci. 49:156–164. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ladner JE, Parsons JF, Rife CL, Gilliland
GL and Armstrong RN: Parallel evolutionary pathways for glutathione
transferases: Structure and mechanism of the mitochondrial class
kappa enzyme rGSTK1-1. Biochemistry. 43:352–361. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hayes JD, Flanagan JU and Jowsey IR:
Glutathione transferases. Annu Rev Pharmacol Toxicol. 45:51–88.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jakobsson PJ, Morgenstern R, Mancini J,
Ford-Hutchinson A and Persson B: Common structural features of
MAPEG - a widespread superfamily of membrane associated proteins
with highly divergent functions in eicosanoid and glutathione
metabolism. Protein Sci. 8:689–692. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Board PG, Coggan M, Chelvanayagam G,
Easteal S, Jermiin LS, Schulte GK, Danley DE, Hoth LR, Griffor MC,
Kamath AV, et al: Identification, characterization, and crystal
structure of the Omega class glutathione transferases. J Biol Chem.
275:24798–24806. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miyanishi K, Takayama T, Ohi M, Hayashi T,
Nobuoka A, Nakajima T, Takimoto R, Kogawa K, Kato J, Sakamaki S, et
al: Glutathione S-transferase-pi overexpression is closely
associated with K-ras mutation during human colon carcinogenesis.
Gastroenterology. 121:865–874. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Morel F, Rauch C, Petit E, Piton A, Theret
N, Coles B and Guillouzo A: Gene and protein characterization of
the human glutathione S-transferase kappa and evidence for a
peroxisomal localization. J Biol Chem. 279:16246–16253. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nordgard SH, Ritchie MD, Jensrud SD,
Motsinger AA, Alnaes GI, Lemmon G, Berg M, Geisler S, Moore JH,
Lønning PE, et al: ABCB1 and GST polymorphisms associated with TP53
status in breast cancer. Pharmacogenet Genomics. 17:127–136. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vasieva O: The many faces of glutathione
transferase pi. Curr Mol Med. 11:129–139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hollman AL, Tchounwou PB and Huang HC: The
Association between Gene-Environment Interactions and Diseases
Involving the Human GST Superfamily with SNP Variants. Int J
Environ Res Public Health. 13:3792016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bolt HM and Thier R: Relevance of the
deletion polymorphisms of the glutathione S-transferases GSTT1 and
GSTM1 in pharmacology and toxicology. Curr Drug Metab. 7:613–628.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pinheiro DS, Rocha Filho CR, Mundim CA,
Júnior PM, Ulhoa CJ, Reis AA and Ghedini PC: Evaluation of
glutathione S-transferase GSTM1 and GSTT1 deletion polymorphisms on
type-2 diabetes mellitus risk. PLoS One. 8:e762622013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yin Z, Ivanov VN, Habelhah H, Tew K and
Ronai Z: Glutathione S-transferase p elicits protection against
H2O2-induced cell death via coordinated regulation of stress
kinases. Cancer Res. 60:4053–4057. 2000.PubMed/NCBI
|
|
16
|
Singh S: Cytoprotective and regulatory
functions of glutathione S-transferases in cancer cell
proliferation and cell death. Cancer Chemother Pharmacol. 75:1–15.
2015. View Article : Google Scholar
|
|
17
|
Salinas AE and Wong MG: Glutathione
S-transferases - a review. Curr Med Chem. 6:279–309.
1999.PubMed/NCBI
|
|
18
|
Hayes JD and Pulford DJ: The glutathione
S-transferase supergene family: Regulation of GST and the
contribution of the isoenzymes to cancer chemoprotection and drug
resistance. Crit Rev Biochem Mol Biol. 30:445–600. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McIlwain CC, Townsend DM and Tew KD:
Glutathione S-transferase polymorphisms: Cancer incidence and
therapy. Oncogene. 25:1639–1648. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hung RJ, van der Hel O, Tavtigian SV,
Brennan P, Boffetta P and Hashibe M: Perspectives on the molecular
epidemiology of aerodigestive tract cancers. Mutat Res.
592:102–118. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schnekenburger M, Karius T and Diederich
M: Regulation of epigenetic traits of the glutathione S-transferase
P1 gene: From detoxification toward cancer prevention and
diagnosis. Front Pharmacol. 5:1702014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brockmöller J, Cascorbi I, Kerb R and
Roots I: Combined analysis of inherited polymorphisms in arylamine
N-acetyltransferase 2, glutathione S-transferases M1 and T1,
microsomal epoxide hydrolase, and cytochrome P450 enzymes as
modulators of bladder cancer risk. Cancer Res. 56:3915–3925.
1996.PubMed/NCBI
|
|
23
|
Cowell IG, Dixon KH, Pemble SE, Ketterer B
and Taylor JB: The structure of the human glutathione S-transferase
pi gene. Biochem J. 255:79–83. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Laborde E: Glutathione transferases as
mediators of signaling pathways involved in cell proliferation and
cell death. Cell Death Differ. 17:1373–1380. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Moyer AM, Salavaggione OE, Wu TY, Moon I,
Eckloff BW, Hildebrandt MA, Schaid DJ, Wieben ED and Weinshilboum
RM: Glutathione s-transferase p1: Gene sequence variation and
functional genomic studies. Cancer Res. 68:4791–4801. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sau A, Pellizzari Tregno F, Valentino F,
Federici G and Caccuri AM: Glutathione transferases and development
of new principles to overcome drug resistance. Arch Biochem
Biophys. 500:116–122. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Henderson CJ, McLaren AW, Moffat GJ, Bacon
EJ and Wolf CR: Pi-class glutathione S-transferase: Regulation and
function. Chem Biol Interact. 111-112:69–82. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nelson WG, De Marzo AM, Deweese TL, Lin X,
Brooks JD, Putzi MJ, Nelson CP, Groopman JD and Kensler TW:
Preneoplastic prostate lesions: An opportunity for prostate cancer
prevention. Ann N Y Acad Sci. 952:135–144. 2001. View Article : Google Scholar
|
|
29
|
Nelson WG, DeWeese TL and DeMarzo AM: The
diet, prostate inflammation, and the development of prostate
cancer. Cancer Metastasis Rev. 21:3–16. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sawers L, Ferguson MJ, Ihrig BR, Young HC,
Chakravarty P, Wolf CR and Smith G: Glutathione S-transferase P1
(GSTP1) directly influences platinum drug chemosensitivity in
ovarian tumour cell lines. Br J Cancer. 111:1150–1158. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hagrman D, Goodisman J and Souid AK:
Kinetic study on the reactions of platinum drugs with glutathione.
J Pharmacol Exp Ther. 308:658–666. 2004. View Article : Google Scholar
|
|
32
|
Zhang J, Wu Y, Hu X, Wang B, Wang L, Zhang
S, Cao J and Wang Z: GSTT1, GSTP1, and GSTM1 genetic variants are
associated with survival in previously untreated metastatic breast
cancer. Oncotarget. 8:105905–105914. 2017.PubMed/NCBI
|
|
33
|
Duvoix A, Schnekenburger M, Delhalle S,
Blasius R, Borde-Chiché P, Morceau F, Dicato M and Diederich M:
Expression of glutathione S-transferase P1-1 in leukemic cells is
regulated by inducible AP-1 binding. Cancer Lett. 216:207–219.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Alqarni MH, Muharram MM and Labrou NE:
Ligand-induced glutathione transferase degradation as a therapeutic
modality: Investigation of a new metal-mediated affinity cleavage
strategy for human GSTP1-1. Int J Biol Macromol. 116:84–90. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pajaud J, Ribault C, Ben Mosbah I, Rauch
C, Henderson C, Bellaud P, Aninat C, Loyer P, Morel F and Corlu A:
Glutathione transferases P1/P2 regulate the timing of signaling
pathway activations and cell cycle progression during mouse liver
regeneration. Cell Death Dis. 6:e15982015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Morceau F, Duvoix A, Delhalle S,
Schnekenburger M, Dicato M and Diederich M: Regulation of
glutathione S-transferase P1-1 gene expression by NF-kappaB in
tumor necrosis factor alpha-treated K562 leukemia cells. Biochem
Pharmacol. 67:1227–1238. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Duvoix A, Morceau F, Delhalle S, Schmitz
M, Schnekenburger M, Galteau MM, Dicato M and Diederich M:
Induction of apoptosis by curcumin: Mediation by glutathione
S-transferase P1-1 inhibition. Biochem Pharmacol. 66:1475–1483.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Duvoix A, Delhalle S, Blasius R,
Schnekenburger M, Morceau F, Fougère M, Henry E, Galteau MM, Dicato
M and Diederich M: Effect of chemopreventive agents on glutathione
S-transferase P1-1 gene expression mechanisms via activating
protein 1 and nuclear factor kappaB inhibition. Biochem Pharmacol.
68:1101–1111. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Moscow JA, Fairchild CR, Madden MJ, Ransom
DT, Wieand HS, O'Brien EE, Poplack DG, Cossman J, Myers CE and
Cowan KH: Expression of anionic glutathione-S-transferase and
P-glycoprotein genes in human tissues and tumors. Cancer Res.
49:1422–1428. 1989.PubMed/NCBI
|
|
40
|
Mian OY, Khattab MH, Hedayati M, Coulter
J, Abubaker-Sharif B, Schwaninger JM, Veeraswamy RK, Brooks JD,
Hopkins L, Shinohara DB, et al: GSTP1 Loss results in accumulation
of oxidative DNA base damage and promotes prostate cancer cell
survival following exposure to protracted oxidative stress.
Prostate. 76:199–206. 2016. View Article : Google Scholar :
|
|
41
|
Rahbar MH, Samms-Vaughan M, Ma J, Bressler
J, Dickerson AS, Hessabi M, Loveland KA, Grove ML,
Shakespeare-Pellington S, Beecher C, et al: Synergic effect of
GSTP1 and blood manganese concentrations in Autism Spectrum
Disorder. Res Autism Spectr Disord. 18:73–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bhang SY, Cho SC, Kim JW, Hong YC, Shin
MS, Yoo HJ, Cho IH, Kim Y and Kim BN: Relationship between blood
manganese levels and children's attention, cognition, behavior, and
academic performance--a nationwide cross-sectional study. Environ
Res. 126:9–16. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rahbar MH, Samms-Vaughan M, Lee M,
Christian MA, Bressler J, Hessabi M, Grove ML,
Shakespeare-Pellington S, Desai CC, Reece JA, et al: Interaction
between manganese and GSTP1 in relation to autism spectrum disorder
while controlling for exposure to mixture of lead, mercury,
arsenic, and cadmium. Res Autism Spectr Disord. 55:50–63. 2018.
View Article : Google Scholar
|
|
44
|
Wright LS, Kornguth SE, Oberley TD and
Siegel FL: Effects of lead on glutathione S-transferase expression
in rat kidney: A dose-response study. Toxicol Sci. 46:254–259.
1998.
|
|
45
|
Li C, Yang X, Xu M, Zhang J and Sun N:
Association between GSTP1 CpG methylation and the early phase of
lead exposure. Toxicol Mech Methods. 24:111–115. 2014. View Article : Google Scholar
|
|
46
|
Kwong YL and Todd D: Delicious poison:
Arsenic trioxide for the treatment of leukemia. Blood.
89:3487–3488. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu J, Chen H, Miller DS, Saavedra JE,
Keefer LK, Johnson DR, Klaassen CD and Waalkes MP: Overexpression
of glutathione S-transferase II and multidrug resistance transport
proteins is associated with acquired tolerance to inorganic
arsenic. Mol Pharmacol. 60:302–309. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Parker LJ, Bocedi A, Ascher DB, Aitken JB,
Harris HH, Lo Bello M, Ricci G, Morton CJ and Parker MW:
Glutathione transferase P1-1 as an arsenic drug-sequestering
enzyme. Protein Sci. 26:317–326. 2017. View Article : Google Scholar
|
|
49
|
González-Martínez F, Sánchez-Rodas D,
Cáceres DD, Martínez MF, Quiñones LA and Johnson-Restrepo B:
Arsenic exposure, profiles of urinary arsenic species, and
polymorphism effects of glutathione-s-transferase and
metallothioneins. Chemosphere. 212:927–936. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhou L, Jing Y, Styblo M, Chen Z and
Waxman S: Glutathione-S-transferase pi inhibits
As2O3-induced apoptosis in lymphoma cells:
Involvement of hydrogen peroxide catabolism. Blood. 105:1198–1203.
2005. View Article : Google Scholar
|
|
51
|
Van Dyck E, Nazarov PV, Muller A, Nicot N,
Bosseler M, Pierson S, Van Moer K, Palissot V, Mascaux C, Knolle U,
et al: Bronchial airway gene expression in smokers with lung or
head and neck cancer. Cancer Med. 3:322–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Krais AM, Mühlbauer KR, Kucab JE, Chinbuah
H, Cornelius MG, Wei QX, Hollstein M, Phillips DH, Arlt VM and
Schmeiser HH: Comparison of the metabolic activation of
environmental carcinogens in mouse embryonic stem cells and mouse
embryonic fibroblasts. Toxicol In Vitro. 29:34–43. 2015. View Article : Google Scholar
|
|
53
|
Gilliland FD, Harms HJ, Crowell RE, Li YF,
Willink R and Belinsky SA: Glutathione S-transferase P1 and NADPH
quinone oxidoreductase polymorphisms are associated with aberrant
promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA
methyltransferase in sputum. Cancer Res. 62:2248–2252.
2002.PubMed/NCBI
|
|
54
|
Xue B, Wu Y, Yin Z, Zhang H, Sun S, Yi T
and Luo L: Regulation of lipopolysaccharide-induced inflammatory
response by glutathione S-transferase P1 in RAW264.7 cells. FEBS
Lett. 579:4081–4087. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yi L, Li L, Yin J, Hu N, Li G and Ding D:
Proteomics analysis of liver tissues from C57BL/6J mice receiving
low-dose 137Cs radiation. Environ Sci Pollut Res Int. 23:2549–2556.
2016. View Article : Google Scholar
|
|
56
|
Yi L, Hu N, Yin J, Sun J, Mu H, Dai K and
Ding D: Up-regulation of calreticulin in mouse liver tissues after
long-term irradiation with low-dose-rate gamma rays. PLoS One.
12:e01826712017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lu M, Xia L, Luo D, Waxman S and Jing Y:
Dual effects of glutathione-S-transferase pi on
As2O3 action in prostate cancer cells:
Enhancement of growth inhibition and inhibition of apoptosis.
Oncogene. 23:3945–3952. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Fujikawa Y, Nampo T, Mori M, Kikkawa M and
Inoue H: Fluorescein diacetate (FDA) and its analogue as substrates
for Pi-class glutathione S-transferase (GSTP1) and their biological
application. Talanta. 179:845–852. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wang J, Ren JH, Lin B, Jing YK and Cheng
MS: Advances of studies on glutathione-S-transferase π. Zhongguo
Yaowu Huaxue Zazhi. 15:251–256. 2005.
|
|
60
|
Ranganathan S and Tew KD:
Immunohistochemical localization of glutathione S-transferases
alpha, mu, and pi in normal tissue and carcinomas from human colon.
Carcinogenesis. 12:2383–2387. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhang R, Kang KA, Piao MJ, Kim KC, Zheng
J, Yao CW, Cha JW, Maeng YH, Chang WY, Moon PG, et al: Epigenetic
alterations are involved in the overexpression of glutathione
S-transferase π-1 in human colorectal cancers. Int J Oncol.
45:1275–1283. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Ding XQ, Bi JH, Ma ZG, Jiang ZX, Xi JF,
Liu PZ and Zhang B: Correlation of ERCC1 and GSTP1 expression in
esophageal cancer tissue with platinum-based chemotherapy
sensitivity as well as apoptosis and proliferation gene expression.
Hainan Yixueyuan Xuebao. 23:103–107. 2017.
|
|
63
|
Song Y, Du Y, Zhou Q, Ma J, Yu J, Tao X
and Zhang F: Association of GSTP1 Ile105Val polymorphism with risk
of esophageal cancer: A meta-analysis of 21 case-control studies.
Int J Clin Exp Med. 7:3215–3224. 2014.PubMed/NCBI
|
|
64
|
Pljesa-Ercegovac M, Savic-Radojevic A,
Dragicevic D, Mimic-Oka J, Matic M, Sasic T, Pekmezovic T,
Vuksanovic A and Simic T: Enhanced GSTP1 expression in transitional
cell carcinoma of urinary bladder is associated with altered
apoptotic pathways. Urol Oncol. 29:70–77. 2011. View Article : Google Scholar
|
|
65
|
Savic-Radojevic A, Mimic-Oka J,
Pljesa-Ercegovac M, Opacic M, Dragicevic D, Kravic T, Djokic M,
Micic S and Simic T: Glutathione S-transferase-P1 expression
correlates with increased antioxidant capacity in transitional cell
carcinoma of the urinary bladder. Eur Urol. 52:470–477. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Gao L, Fang YQ, Zhang TY, Ge B, Xu B,
Huang JF, Zhang ZF and Tan N: GSTP1 arrests bladder cancer T24
cells in G0/G1 phase and up-regulates p21 expression. Int J Clin
Exp Med. 7:2984–2991. 2014.PubMed/NCBI
|
|
67
|
Oguztuzun Serpil, Ergün Duygu, Kilic
Murat, Bozer Busra, Simsek Gulcin Güler and Bulus Hakan: The
expression of GST and CYP isoenzymes in thyroid nodular hyperplasia
and papillary thyroid cancer tissue: Correlation with clinical
parameters. Entomol Appl Sci Lett. 5:97–103. 2016.
|
|
68
|
Dong X, Yang Y, Zhou Y, Bi X, Zhao N,
Zhang Z, Li L, Hang Q, Zhang R, Chen D, et al: Glutathione
S-transferases P1 protects breast cancer cell from
adriamycin-induced cell death through promoting autophagy. Cell
Death Differ. 26:2086–2099. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Liu X, Tan N, Liao H, Pan G, Xu Q, Zhu R,
Zou L, He S and Zhu H: High GSTP1 inhibits cell proliferation by
reducing Akt phosphorylation and is associated with a better
prognosis in hepatocellular carcinoma. Oncotarget. 9:8957–8971.
2017.
|
|
70
|
Depeille P, Cuq P, Passagne I, Evrard A
and Vian L: Combined effects of GSTP1 and MRP1 in melanoma drug
resistance. Br J Cancer. 93:216–223. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Lin C, Xie L, Lu Y, Hu Z and Chang J:
miR-133b reverses cisplatin resistance by targeting GSTP1 in
cisplatin-resistant lung cancer cells. Int J Mol Med. 41:2050–2058.
2018.PubMed/NCBI
|
|
72
|
Zong C, Wang J and Shi TM: MicroRNA 130b
enhances drug resistance in human ovarian cancer cells. Tumour
Biol. 35:12151–12156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Uchida Y, Chiyomaru T, Enokida H, Kawakami
K, Tatarano S, Kawahara K, Nishiyama K, Seki N and Nakagawa M:
MiR-133a induces apoptosis through direct regulation of GSTP1 in
bladder cancer cell lines. Urol Oncol. 31:115–123. 2013. View Article : Google Scholar
|
|
74
|
Mutallip M, Nohata N, Hanazawa T, Kikkawa
N, Horiguchi S, Fujimura L, Kawakami K, Chiyomaru T, Enokida H,
Nakagawa M, et al: Glutathione S-transferase P1 (GSTP1) suppresses
cell apoptosis and its regulation by miR-133α in head and neck
squamous cell carcinoma (HNSCC). Int J Mol Med. 27:345–352.
2011.
|
|
75
|
Zhu J, Zhang R, Yang D, Li J, Yan X, Jin
K, Li W, Liu X, Zhao J, Shang W, et al: Knockdown of Long
Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal
Cancer by Upregulation of miR-124 and Downregulation of SGK1. Cell
Physiol Biochem. 51:113–128. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhang X, Zhu J, Xing R, Tie Y, Fu H, Zheng
X and Yu B: miR-513a-3p sensitizes human lung adenocarcinoma cells
to chemotherapy by targeting GSTP1. Lung Cancer. 77:488–494. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Song X, Wang R, Xiao F, Zhang SX, Gong M,
Wang XL, Zhang Y and Huang JY: Expressions of glutathione
S-transferase P1 and 4-hydroxynonenal and the progression of
prostate cancer. Zhonghua Nan Ke Xue. 23:412–416. 2017.In
Chinese.
|
|
78
|
Singh S, Shukla GC and Gupta S: MicroRNA
Regulating Glutathione S-Transferase P1 in Prostate Cancer. Curr
Pharmacol Rep. 1:79–88. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kanwal R, Pandey M, Bhaskaran N, Maclennan
GT, Fu P, Ponsky LE and Gupta S: Protection against oxidative DNA
damage and stress in human prostate by glutathione S-transferase
P1. Mol Carcinog. 53:8–18. 2014. View Article : Google Scholar :
|
|
80
|
Miyake T, Nakayama T, Naoi Y, Yamamoto N,
Otani Y, Kim SJ, Shimazu K, Shimomura A, Maruyama N, Tamaki Y, et
al: GSTP1 expression predicts poor pathological complete response
to neoadjuvant chemotherapy in ER-negative breast cancer. Cancer
Sci. 103:913–920. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Gurioli G, Martignano F, Salvi S,
Costantini M, Gunelli R and Casadio V: GSTP1 methylation in cancer:
A liquid biopsy biomarker? Clin Chem Lab Med. 56:702–717. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Li Y, Cai Y, Chen H and Mao L: Clinical
significance and association of GSTP1 hypermethylation with
hepatocellular carcinoma: A meta-analysis. J Cancer Res Ther.
14(Suppl): S486–S489. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Li QF, Li QY, Gao AR and Shi QF:
Correlation between promoter methylation in the GSTP1 gene and
hepatocellular carcinoma development: A meta-analysis. Genet Mol
Res. 14:6762–6772. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Jain S, Chen S, Chang KC, Lin YJ, Hu CT,
Boldbaatar B, Hamilton JP, Lin SY, Chang TT, Chen SH, et al: Impact
of the location of CpG methylation within the GSTP1 gene on its
specificity as a DNA marker for hepatocellular carcinoma. PLoS One.
7:e357892012. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Qu Z, Jiang Y, Li H, Yu DC and Ding YT:
Detecting abnormal methylation of tumor suppressor genes GSTP1,
P16, RIZ1, and RASSF1A in hepatocellular carcinoma and its clinical
significance. Oncol Lett. 10:2553–2558. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Gao S, Sun FK, Fan YC, Shi CH, Zhang ZH,
Wang LY and Wang K: Aberrant GSTP1 promoter methylation predicts
short-term prognosis in acute-on-chronic hepatitis B liver failure.
Aliment Pharmacol Ther. 42:319–329. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Costa VL, Henrique R and Jerónimo C:
Epigenetic markers for molecular detection of prostate cancer. Dis
Markers. 23:31–41. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Goering W, Kloth M and Schulz WA: DNA
methylation changes in prostate cancer. Methods Mol Biol.
863:47–66. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Maldonado L, Brait M, Loyo M, Sullenberger
L, Wang K, Peskoe SB, Rosenbaum E, Howard R, Toubaji A, Albadine R,
et al: GSTP1 promoter methylation is associated with recurrence in
early stage prostate cancer. J Urol. 192:1542–1548. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Zelic R, Fiano V, Zugna D, Grasso C,
Delsedime L, Daniele L, Galliano D, Pettersson A, Gillio-Tos A,
Merletti F, et al: Global Hypomethylation (LINE-1) and
Gene-Specific Hypermethylation (GSTP1) on Initial Negative Prostate
Biopsy as Markers of Prostate Cancer on a Rebiopsy. Clin Cancer
Res. 22:984–992. 2016. View Article : Google Scholar
|
|
91
|
Lee WH, Morton RA, Epstein JI, Brooks JD,
Campbell PA, Bova GS, Hsieh WS, Isaacs WB and Nelson WG: Cytidine
methylation of regulatory sequences near the pi-class glutathione
S-transferase gene accompanies human prostatic carcinogenesis. Proc
Natl Acad Sci USA. 91:11733–11737. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Haluskova J, Lachvac L and Nagy V: The
investigation of GSTP1, APC and RASSF1 gene promoter
hypermethylation in urine DNA of prostate-diseased patients.
Bratisl Lek Listy. 116:79–82. 2015.PubMed/NCBI
|
|
93
|
Lee JS: GSTP1 promoter hypermethylation is
an early event in breast carcinogenesis. Virchows Arch.
450:637–642. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Alnaes GI, Ronneberg JA, Kristensen VN and
Tost J: Heterogeneous DNA Methylation Patterns in the GSTP1
Promoter Lead to Discordant Results between Assay Technologies and
Impede Its Implementation as Epigenetic Biomarkers in Breast
Cancer. Genes (Basel). 6:878–900. 2015. View Article : Google Scholar
|
|
95
|
Miyake T, Nakayama T, Kagara N, Yamamoto
N, Nakamura Y, Otani Y, Uji K, Naoi Y, Shimoda M, Maruyama N, et
al: Association of GSTP1 methylation with aggressive phenotype in
ER-positive breast cancer. Anticancer Res. 33:5617–5623.
2013.PubMed/NCBI
|
|
96
|
Muggerud AA, Rønneberg JA, Wärnberg F,
Botling J, Busato F, Jovanovic J, Solvang H, Bukholm I,
Børresen-Dale AL, Kristensen VN, et al: Frequent aberrant DNA
methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma
in situ and early invasive breast cancer. Breast Cancer Res.
12:R32010. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Feng W, Shen L, Wen S, Rosen DG, Jelinek
J, Hu X, Huan S, Huang M, Liu J, Sahin AA, et al: Correlation
between CpG methylation profiles and hormone receptor status in
breast cancers. Breast Cancer Res. 9:R572007. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Sunami E, Shinozaki M, Sim MS, Nguyen SL,
Vu AT, Giuliano AE and Hoon DS: Estrogen receptor and HER2/neu
status affect epigenetic differences of tumor-related genes in
primary breast tumors. Breast Cancer Res. 10:R462008. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Song B, Wang L, Zhang Y, Li N, Dai H, Xu
H, Cai H and Yan J: Combined Detection of HER2, Ki67, and GSTP1
Genes on the Diagnosis and Prognosis of Breast Cancer. Cancer
Biother Radiopharm. 34:85–90. 2019. View Article : Google Scholar
|
|
100
|
Yanagawa N, Tamura G, Oizumi H, Takahashi
N, Shimazaki Y and Motoyama T: Promoter hypermethylation of tumor
suppressor and tumor-related genes in non-small cell lung cancers.
Cancer Sci. 94:589–592. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Russo AL, Thiagalingam A, Pan H, Califano
J, Cheng KH, Ponte JF, Chinnappan D, Nemani P, Sidransky D and
Thiagalingam S: Differential DNA hypermethylation of critical genes
mediates the stage-specific tobacco smoke-induced neoplastic
progression of lung cancer. Clin Cancer Res. 11:2466–2470. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Vaissière T, Hung RJ, Zaridze D, Moukeria
A, Cuenin C, Fasolo V, Ferro G, Paliwal A, Hainaut P, Brennan P, et
al: Quantitative analysis of DNA methylation profiles in lung
cancer identifies aberrant DNA methylation of specific genes and
its association with gender and cancer risk factors. Cancer Res.
69:243–252. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Haroun RA, Zakhary NI, Mohamed MR,
Abdelrahman AM, Kandil EI and Shalaby KA: Assessment of the
prognostic value of methylation status and expression levels of
FHIT, GSTP1 and p16 in non-small cell lung cancer in Egyptian
patients. Asian Pac J Cancer Prev. 15:4281–4287. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Drilon A, Sugita H, Sima CS, Zauderer M,
Rudin CM, Kris MG, Rusch VW and Azzoli CG: A prospective study of
tumor suppressor gene methylation as a prognostic biomarker in
surgically resected stage I to IIIA non-small-cell lung cancers. J
Thorac Oncol. 9:1272–1277. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Kim DS, Cha SI, Lee JH, Lee YM, Choi JE,
Kim MJ, Lim JS, Lee EB, Kim CH, Park TI, et al: Aberrant DNA
methylation profiles of non-small cell lung cancers in a Korean
population. Lung Cancer. 58:1–6. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Gumy-Pause F, Pardo B, Khoshbeen-Boudal M,
Ansari M, Gayet-Ageron A, Sappino AP, Attiyeh EF and Ozsahin H:
GSTP1 hypermethylation is associated with reduced protein
expression, aggressive disease and prognosis in neuroblastoma.
Genes Chromosomes Cancer. 51:174–185. 2012. View Article : Google Scholar
|
|
107
|
Ferraù F, Romeo PD, Puglisi S, Ragonese M,
Spagnolo F, Salpietro C, Ientile R, Currò M, Visalli G, Alibrandi
A, et al: GSTP1 gene methylation and AHR rs2066853 variant predict
resistance to first generation somatostatin analogs in patients
with acromegaly. J Endocrinol Invest. 2018.
|
|
108
|
Ali-Osman F, Akande O, Antoun G, Mao JX
and Buolamwini J: Molecular cloning, characterization, and
expression in Escherichia coli of full-length cDNAs of three human
glutathione S-transferase Pi gene variants. Evidence for
differential catalytic activity of the encoded proteins. J Biol
Chem. 272:10004–10012. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Cote ML, Chen W, Smith DW, Benhamou S,
Bouchardy C, Butkiewicz D, Fong KM, Gené M, Hirvonen A, Kiyohara C,
et al: Meta- and pooled analysis of GSTP1 polymorphism and lung
cancer: A HuGE-GSEC review. Am J Epidemiol. 169:802–814. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Pérez-Ramírez C, Cañadas-Garre M, Alnatsha
A, Villar E, Delgado JR, Calleja-Hernández MÁ and Faus-Dáder MJ:
Impact of DNA repair, folate and glutathione gene polymorphisms on
risk of non small cell lung cancer. Pathol Res Pract. 214:44–52.
2018. View Article : Google Scholar
|
|
111
|
Saarikoski ST, Voho A, Reinikainen M,
Anttila S, Karjalainen A, Malaveille C, Vainio H,
Husgafvel-Pursiainen K and Hirvonen A: Combined effect of
polymorphic GST genes on individual susceptibility to lung cancer.
Int J Cancer. 77:516–521. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Li XM, Yu XW, Yuan Y, Pu MZ, Zhang HX,
Wang KJ and Han XD: Glutathione S-transferase P1, gene-gene
interaction, and lung cancer susceptibility in the Chinese
population: An updated meta-analysis and review. J Cancer Res Ther.
11:565–570. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Tarek F: Role of glutathione S-transferase
P-1 (GSTP-1) gene polymorphism in COPD patients. Egypt J Chest Dis
Tuberc. 65:739–744. 2016. View Article : Google Scholar
|
|
114
|
Lakhdar R, Denden S, Knani J, Leban N,
Daimi H, Hassine M, Lefranc G, Ben Chibani J and Haj Khelil A:
Relationship between glutathione S-transferase P1 polymorphisms and
chronic obstructive pulmonary disease in a Tunisian population.
Genet Mol Res. 9:897–907. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Wang Y, Ren BU, Zhang L and Guo Z:
Correlation between metabolic enzyme GSTP1 polymorphisms and
susceptibility to lung cancer. Exp Ther Med. 10:1521–1527. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
He L, Gao L, Shi Z, Li Y, Zhu L, Li S,
Zhang P, Zheng G, Ren Q, Li Y, et al: Involvement of cytochrome
P450 1A1 and glutathione S-transferase P1 polymorphisms and
promoter hypermethylation in the progression of anti-tuberculosis
drug-induced liver injury: A case-control study. PLoS One.
10:e01194812015. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Qu K, Liu SS, Wang ZX, Huang ZC, Liu SN,
Chang HL, Xu XS, Lin T, Dong YF and Liu C: Polymorphisms of
glutathione S-transferase genes and survival of resected
hepatocellular carcinoma patients. World J Gastroenterol.
21:4310–4322. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Song QB, Wang Q and Hu WG: A systemic
review of glutathione S-transferase P1 Ile105Val polymorphism and
colorectal cancer risk. Chin J Cancer Res. 26:255–267.
2014.PubMed/NCBI
|
|
119
|
Lei Z, Liu T, Li X, Xu X and Fan D:
Contribution of glutathione S-transferase gene polymorphisms to
development of skin cancer. Int J Clin Exp Med. 8:377–386.
2015.PubMed/NCBI
|
|
120
|
Lira MG, Provezza L, Malerba G, Naldi L,
Remuzzi G, Boschiero L, Forni A, Rugiu C, Piaserico S, Alaibac M,
et al: Glutathione S-transferase and CYP1A1 gene polymorphisms and
non-melanoma skin cancer risk in Italian transplanted patients. Exp
Dermatol. 15:958–965. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Gsur A, Haidinger G, Hinteregger S,
Bernhofer G, Schatzl G, Madersbacher S, Marberger M, Vutuc C and
Micksche M: Polymorphisms of glutathione-S-transferase genes
(GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int J Cancer.
95:152–155. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Harries LW, Stubbins MJ, Forman D, Howard
GC and Wolf CR: Identification of genetic polymorphisms at the
glutathione S-transferase Pi locus and association with
susceptibility to bladder, testicular and prostate cancer.
Carcinogenesis. 18:641–644. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Chen ZH, Xian JF and Luo LP: Association
between GSTM1, GSTT1, and GSTP1 polymorphisms and gastric cancer
risk, and their interactions with environmental factors. Genet Mol
Res. 16:gmr160188772017. View Article : Google Scholar
|
|
124
|
Nguyen TV, Janssen MJ, van Oijen MG,
Bergevoet SM, te Morsche RH, van Asten H, Laheij RJ, Peters WH and
Jansent JB: Genetic polymorphisms in GSTA1, GSTP1, GSTT1, and GSTM1
and gastric cancer risk in a Vietnamese population. Oncol Res.
18:349–355. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Negovan A, Iancu M, Moldovan V, Mocan S
and Banescu C: The Interaction between GSTT1, GSTM1, and GSTP1
Ile105Val Gene Polymorphisms and Environmental Risk Factors in
Premalignant Gastric Lesions Risk. BioMed Res Int.
2017:73650802017. View Article : Google Scholar :
|
|
126
|
Tripathi S, Ghoshal U, Ghoshal UC, Mittal
B, Krishnani N, Chourasia D, Agarwal AK and Singh K: Gastric
carcinogenesis: Possible role of polymorphisms of GSTM1, GSTT1, and
GSTP1 genes. Scand J Gastroenterol. 43:431–439. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Jiao L, Bondy ML, Hassan MM, Chang DZ,
Abbruzzese JL, Evans DB, Smolensky MH and Li D: Glutathione
S-transferase gene polymorphisms and risk and survival of
pancreatic cancer. Cancer. 109:840–848. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Liu S, Yi Z, Ling M, Shi J, Qiu Y and Yang
S: Predictive potential of ABCB1, ABCC3, and GSTP1 gene
polymorphisms on osteosarcoma survival after chemotherapy. Tumour
Biol. 35:9897–9904. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Wei L, Song XR, Wang XW, Li M and Zuo WS:
Expression of MDR1 and GST-pi in osteosarcoma and soft tissue
sarcoma and their correlation with chemotherapy resistance.
Zhonghua Zhong Liu Za Zhi. 28:445–448. 2006.In Chinese. PubMed/NCBI
|
|
130
|
Zhang SL, Mao NF, Sun JY, Shi ZC, Wang B
and Sun YJ: Predictive potential of glutathione S-transferase
polymorphisms for prognosis of osteosarcoma patients on
chemotherapy. Asian Pac J Cancer Prev. 13:2705–2709. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Yang LM, Li XH and Bao CF: Glutathione
S-transferase P1 and DNA polymorphisms influence response to
chemotherapy and prognosis of bone tumors. Asian Pac J Cancer Prev.
13:5883–5886. 2012. View Article : Google Scholar
|
|
132
|
Ben Ami T, Sarig O, Sprecher E and
Goldberg I: Glutathione S-transferase polymorphisms in patients
with photosensitive and non-photosensitive drug eruptions.
Photodermatol Photoimmunol Photomed. 35:214–220. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Rajesh D, Balakrishna S, Azeem Mohiyuddin
SM, Suryanarayana R and Kutty AVM: Novel association of oral
squamous cell carcinoma with GSTP1 Arg187Trp gene polymorphism. J
Cell Biochem. 120:5906–5912. 2019. View Article : Google Scholar
|
|
134
|
Dunna NR, Vuree S, Kagita S, Surekha D,
Digumarti R, Rajappa S and Satti V: Association of GSTP1 gene
(I105V) polymorphism with acute leukaemia. J Genet. 91:e60–e63.
2012.PubMed/NCBI
|
|
135
|
Allan JM, Wild CP, Rollinson S, Willett
EV, Moorman AV, Dovey GJ, Roddam PL, Roman E, Cartwright RA and
Morgan GJ: Polymorphism in glutathione S-transferase P1 is
associated with susceptibility to chemotherapy-induced leukemia.
Proc Natl Acad Sci USA. 98:11592–11597. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Daraki A, Zachaki S, Rosmaraki F,
Kalomoiraki M, Aleporou-Marinou V, Sambani C, Kollia P and Manola
KN: Association of GSTP1 inactivating polymorphism with acute
myeloid leukemia and its specific chromosomal abnormalities. Leuk
Lymphoma. 58:2505–2507. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Bănescu C, Iancu M, Trifa AP, Cândea M,
Benedek Lazar E, Moldovan VG, Duicu C, Tripon F, Crauciuc A and
Dobreanu M: From Six Gene Polymorphisms of the Antioxidant System,
Only GPX Pro198Leu and GSTP1 Ile105Val Modulate the Risk of Acute
Myeloid Leukemia. Oxid Med Cell Longev. 2016:25367052016.
View Article : Google Scholar
|
|
138
|
Bănescu C, Trifa AP, Voidăzan S, Moldovan
VG, Macarie I, Benedek Lazar E, Dima D, Duicu C and Dobreanu M:
CAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 genetic polymorphisms in
chronic myeloid leukemia: A case-control study. Oxid Med Cell
Longev. 2014:8758612014. View Article : Google Scholar
|
|
139
|
He HR, Zhang XX, Sun JY, Hu SS, Ma Y, Dong
YL and Lu J: Glutathione S-transferase gene polymorphisms and
susceptibility to chronic myeloid leukemia. Tumour Biol.
35:6119–6125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Sailaja K, Surekha D, Rao DN, Rao DR and
Vishnupriya S: Association of the GSTP1 gene (Ile105Val)
polymorphism with chronic myeloid leukemia. Asian Pac J Cancer
Prev. 11:461–464. 2010.PubMed/NCBI
|
|
141
|
Kasznicki J, Kosmalski M, Sliwinska A,
Mrowicka M, Stanczyk M, Majsterek I and Drzewoski J: Evaluation of
oxidative stress markers in pathogenesis of diabetic neuropathy.
Mol Biol Rep. 39:8669–8678. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Stoian A, Bănescu C, Bălaşa RI, Moţăţăianu
A, Stoian M, Moldovan VG, Voidăzan S and Dobreanu M: Influence of
GSTM1, GSTT1, and GSTP1 Polymorphisms on Type 2 Diabetes Mellitus
and Diabetic Sensorimotor Peripheral Neuropathy Risk. Dis Markers.
2015:6386932015. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Qiu YH, Xu YL and Zhang WH: Effect of
GSTM1, GSTT1, and GSTP1 IIe105Val polymorphisms on susceptiblity to
gestational diabetes mellitus. Genet Mol Res. 15:gmr.150277112016.
View Article : Google Scholar
|
|
144
|
Mir O, Alexandre J, Tran A, Durand JP,
Pons G, Treluyer JM and Goldwasser F: Relationship between GSTP1
Ile(105)Val polymorphism and docetaxel-induced peripheral
neuropathy: Clinical evidence of a role of oxidative stress in
taxane toxicity. Ann Oncol. 20:736–740. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Gajewska B, Kaźmierczak B,
Kuźma-Kozakiewicz M, Jamrozik Z and Barańczyk-Kuźma A: GSTP1
Polymorphisms and their Association with Glutathione Transferase
and Peroxidase Activities in Patients with Motor Neuron Disease.
CNS Neurol Disord Drug Targets. 14:1328–1333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Pastor S, Rodríguez-Ribera L, Corredor Z,
da Silva Filho MI, Hemminki K, Coll E, Försti A and Marcos R:
Levels of DNA damage (Micronuclei) in patients suffering from
chronic kidney diseaseRole of GST polymorphisms. Mutat Res Genet
Toxicol Environ Mutagen. 836(Pt A): 41–46. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Agusa T, Kunito T, Tue NM, Lan VT,
Fujihara J, Takeshita H, Minh TB, Trang PT, Takahashi S, Viet PH,
et al: Individual variations in arsenic metabolism in Vietnamese:
The association with arsenic exposure and GSTP1 genetic
polymorphism. Metallomics. 4:91–100. 2012. View Article : Google Scholar
|
|
148
|
Stoyanova E, Pastor S, Coll E, Azqueta A,
Collins AR and Marcos R: Base excision repair capacity in chronic
renal failure patients undergoing hemodialysis treatment. Cell
Biochem Funct. 32:177–182. 2014. View Article : Google Scholar
|
|
149
|
Lok HC, Suryo Rahmanto Y, Hawkins CL,
Kalinowski DS, Morrow CS, Townsend AJ, Ponka P and Richardson DR:
Nitric oxide storage and transport in cells are mediated by
glutathione S-transferase P1-1 and multidrug resistance protein 1
via dinitrosyl iron complexes. J Biol Chem. 287:607–618. 2012.
View Article : Google Scholar :
|
|
150
|
Suryo Rahmanto Y, Kalinowski DS, Lane DJ,
Lok HC, Richardson V and Richardson DR: Nitrogen monoxide (NO)
storage and transport by dinitrosyl-dithiol-iron complexes:
Long-lived NO that is trafficked by interacting proteins. J Biol
Chem. 287:6960–6968. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Lok HC, Sahni S, Richardson V, Kalinowski
DS, Kovacevic Z, Lane DJ and Richardson DR: Glutathione
S-transferase and MRP1 form an integrated system involved in the
storage and transport of dinitrosyldithiolato iron complexes in
cells. Free Radic Biol Med. 75:14–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Lok HC, Sahni S, Jansson PJ, Kovacevic Z,
Hawkins CL and Richardson DR: A Nitric Oxide Storage and Transport
System That Protects Activated Macrophages from Endogenous Nitric
Oxide Cytotoxicity. J Biol Chem. 291:27042–27061. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Kovacevic Z, Sahni S, Lok H, Davies MJ,
Wink DA and Richardson DR: Regulation and control of nitric oxide
(NO) in macrophages: Protecting the "professional killer cell" from
its own cytotoxic arsenal via MRP1 and GSTP1. Biochim Biophys Acta,
Gen Subj. 1861(5 Pt A): 995–999. 2017. View Article : Google Scholar
|
|
154
|
Cao X, Kong X, Zhou Y, Lan L, Luo L and
Yin Z: Glutathione S-transferase P1 suppresses iNOS protein
stability in RAW264.7 macrophage-like cells after LPS stimulation.
Free Radic Res. 49:1438–1448. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Zhang B, Jing C, Li X and Wang J: Effect
of 1-octyl-3-methyl-imidazolium bromide on the expressions of
CYP1A1, CYP1A2, CYP3A4, and GSTP1, and the receptors AhR, ARNT, and
PXR in HepG2 cells. J Toxicol Toxin Rev. 34:72015. View Article : Google Scholar
|
|
156
|
Kim Y, Maciag AE, Cao Z, Deschamps JR,
Saavedra JE, Keefer LK and Holland RJ: PABA/NO lead optimization:
Improved targeting of cytotoxicity to glutathione S-transferase
P1-overexpressing cancer cells. Bioorg Med Chem. 23:4980–4988.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Adler V, Yin Z, Fuchs SY, Benezra M,
Rosario L, Tew KD, Pincus MR, Sardana M, Henderson CJ, Wolf CR, et
al: Regulation of JNK signaling by GSTp. EMBO J. 18:1321–1334.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Wang T, Arifoglu P, Ronai Z and Tew KD:
Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal
kinase (JNK1) signaling through interaction with the C terminus. J
Biol Chem. 276:20999–21003. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Tew KD and Townsend DM: Regulatory
functions of glutathione S-transferase P1-1 unrelated to
detoxification. Drug Metab Rev. 43:179–193. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Okamura T, Antoun G, Keir ST, Friedman H,
Bigner DD and Ali-Osman F: Phosphorylation of Glutathione
S-Transferase P1 (GSTP1) by Epidermal Growth Factor Receptor (EGFR)
Promotes Formation of the GSTP1-c-Jun N-terminal kinase (JNK)
Complex and Suppresses JNK Downstream Signaling and Apoptosis in
Brain Tumor Cells. J Biol Chem. 290:30866–30878. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Elsby R, Kitteringham NR, Goldring CE,
Lovatt CA, Chamberlain M, Henderson CJ, Wolf CR and Park BK:
Increased constitutive c-Jun N-terminal kinase signaling in mice
lacking glutathione S-transferase Pi. J Biol Chem. 278:22243–22249.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Yin ZM, Liu AH and Jiang Y: Glutathione
S-transferase pi Protects Serum Depletion-induced Cell Death by
Inhibiting ASK1-MKK7-JNK Pathway in the 293 Cells. Sheng Wu Hua Xue
Yu Sheng Wu Wu Li Xue Bao (Shanghai). 33:185–190. 2001.
|
|
163
|
Liu X, An BH, Kim MJ, Park JH, Kang YS and
Chang M: Human glutathione S-transferase P1-1 functions as an
estrogen receptor α signaling modulator. Biochem Biophys Res
Commun. 452:840–844. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Sun KH, Chang KH, Clawson S, Ghosh S,
Mirzaei H, Regnier F and Shah K: Glutathione-S-transferase P1 is a
critical regulator of Cdk5 kinase activity. J Neurochem.
118:902–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Wan Hasan WN, Kwak MK, Makpol S, Wan Ngah
WZ and Mohd Yusof YA: Piper betle induces phase I & II genes
through Nrf2/ARE signaling pathway in mouse embryonic fibroblasts
derived from wild type and Nrf2 knockout cells. BMC Complement
Altern Med. 14:722014. View Article : Google Scholar :
|
